Shares of Assura Plc (LON:AGR - Get Free Report) reached a new 52-week low during trading on Tuesday . The stock traded as low as GBX 35.60 ($0.43) and last traded at GBX 35.60 ($0.43), with a volume of 14356275 shares changing hands. The stock had previously closed at GBX 36.14 ($0.44).
Analysts Set New Price Targets
Separately, Berenberg Bank reissued a "buy" rating and set a GBX 51 ($0.62) price objective on shares of Assura in a research note on Tuesday, September 17th.
View Our Latest Stock Analysis on Assura
Assura Trading Down 2.2 %
The business has a 50 day simple moving average of GBX 38.47 and a two-hundred day simple moving average of GBX 40.38. The stock has a market cap of £1.15 billion, a price-to-earnings ratio of -3,534.00, a price-to-earnings-growth ratio of 3.60 and a beta of 0.37. The company has a current ratio of 0.89, a quick ratio of 2.84 and a debt-to-equity ratio of 85.04.
Assura Dividend Announcement
The company also recently disclosed a dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, December 12th will be issued a GBX 0.84 ($0.01) dividend. This represents a yield of 2.12%. The ex-dividend date is Thursday, December 12th. Assura's dividend payout ratio is currently -30,000.00%.
About Assura
(
Get Free Report)
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 - the first FTSE 250 business to do so.
Read More
Before you consider Assura, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Assura wasn't on the list.
While Assura currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.